The 17th patient in a trial of the Neuro-Spinal Scaffold has been enrolled by InVivo Therapeutics. The study seeks to evaluate the safety and efficacy of the device in treating patients with complete thoracic AIS A spinal cord injury.
Trial advances for InVivo Therapeutics' neurospinal scaffold
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.